SD
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
7 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Congressman Tom Davis
Disclosed on LD-2 filings
Career
FK
Specific issues
IRA, Part D redesign, rebates, AMP CAP, inflationary penalties, mid-year formulary changes, patent reform, terminal disclaimers, ancillary product patents
Pharmaceutical supply chain and API procurement, Global drug shortages, Tax reform
Rebate reform, any willing pharmacy, PBM reform, IRA Medicare Direct Negotiation, DIR fees
Tax incentives for American production of pharmaceutical product, opioid taxes
IRA, Part D redesign, rebates, AMP CAP, inflationary penalties, mid-year formulary changes
Rebate reform, any willing pharmacy, PBMs, IRA Medicare Direct Negotiation, DIR fees